Related Experiment Video
Updated: Aug 24, 2026

One-step Metabolomics: Carbohydrates, Organic and Amino Acids Quantified in a Single Procedure
Published on: June 25, 2010
Normal infant by a gestational carrier for a phenylketonuria mother: alternative therapy
Robert O Fisch1, Jacques P Stassart
1Department of Pediatrics, University of Minnesota, Minneapolis, MN 55455, USA. fisch001@umn.edu
Insights
Pregnancies in untreated phenylketonuria (PKU) mothers pose risks to fetal development. A successful term pregnancy using a gestational carrier offered a healthy infant to an untreated PKU mother, presenting a new option.
Area of Science:
- Reproductive Medicine
- Metabolic Disorders
- Genetics
Background:
- Untreated phenylketonuria (PKU) in mothers leads to severe fetal complications, including miscarriage, growth restriction, and developmental issues.
- These abnormalities are attributed to the intrauterine environment, not genetic factors, as PKU fathers have normal children.
- Maternal dietary control before and during pregnancy is crucial but not always effective in preventing fetal complications.
Observation:
- A 26-year-old fertile woman with PKU underwent controlled ovarian stimulation and IVF.
- Her oocytes were fertilized with her husband's sperm, and two embryos were transferred to a gestational carrier.
- The gestational carrier had a successful term pregnancy, delivering a healthy male infant without abnormalities.
Findings:
- The infant born to the untreated PKU mother via gestational carrier was normal at birth and at one year of age.
- This represents the first reported successful term pregnancy in an untreated PKU mother using a gestational carrier.
- The infant exhibited normal growth and developmental assessments.
Implications:
- Gestational carrier surrogacy offers a viable alternative for women with PKU unable or unwilling to adhere to strict dietary management.
- This approach can help prevent the adverse intrauterine environmental effects of maternal PKU on fetal development.
- It provides a pathway to healthy offspring for PKU patients, improving reproductive outcomes.
Abstract:
The consequences of pregnancies in untreated phenylketonuria (PKU) mothers are a high incidence of spontaneous abortion, intrauterine growth retardation with microcephaly, congenital malformations, and abnormal intellectual development. PKU fathers, on the other hand, produce normal children. Obviously children of PKU women and men are at least heterozygous, proving that the abnormalities produced by the PKU mothers are not genetic but "intrauterinely environmental." Exposure to the mother's metabolic abnormalities affects the fetus during the entire pregnancy. A PKU mother can produce a healthy infant if she maintains a very restricted and controlled diet before and during pregnancy. However, even the most recent reports describe a very high incidence of congenitally abnormal children of PKU mothers, hence dietary compliance is not working in all cases. A 26-year-old PKU patient with proven fertility underwent standard ovarian stimulation in preparation for oocyte retrieval. Following conventional co-incubation of the oocytes and her husband's sperm, two embryos were transferred to the gestational carrier's uterine cavity, resulting in a single intrauterine pregnancy. Birth was induced at 39 weeks of gestation. The male infant weighed 3486 g. Head circumference was 36 cm and length 50.5 cm; there was no evidence of any abnormality and/or malformation. At 1 year of age, the child's growth measurements and development assessments were normal. This describes the first reported successful term pregnancy of an untreated PKU mother with the help of a gestational carrier (GC), producing a normal infant. This is an alternative method that should be offered to PKU women who are unable and/or unwilling to maintain a well controlled diet before and during pregnancy.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase
Gene Therapy
Pharmacokinetics in Pediatric Patients: Drug Excretion
Teratogenicity
Overview of Protein Metabolism
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...

